Gefitinib Sandoz

Gefitinib Sandoz is an oral medication used for targeted therapy in certain types of cancer. This pharmaceutical is designed to inhibit specific proteins that contribute to cancer cell growth.

Gefitinib Sandoz is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has specific mutations. It works by targeting and blocking the epidermal growth factor receptor (EGFR), which can help slow down the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' and the answer lies in its ability to provide targeted therapy for certain cancer types.

Common effects of Gefitinib Sandoz may include skin rash, diarrhea, and fatigue. Some users may also experience nausea or loss of appetite. These effects can vary from person to person and are not exhaustive.

Gefitinib Sandoz should be handled with care and stored as directed. It is important to follow the advice of a healthcare professional regarding its use. Patients with certain medical conditions or allergies should consult their doctor before taking this medication.

Gefitinib Sandoz may interact with other medications, including those that are metabolized by the liver. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect its efficacy.